Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Colorectal Carcinoma
|
1962 | 0.611 | 0.600 | 16 | 50722629 | missense variant | G/C;T | snv | 1.1E-02; 2.2E-04 | 0.060 | 0.833 | 6 | 2005 | 2014 | |||||
Malignant Neoplasms
|
1641 | 0.611 | 0.600 | 16 | 50722629 | missense variant | G/C;T | snv | 1.1E-02; 2.2E-04 | 0.030 | 0.667 | 3 | 2005 | 2014 | |||||
Primary malignant neoplasm
|
1374 | 0.611 | 0.600 | 16 | 50722629 | missense variant | G/C;T | snv | 1.1E-02; 2.2E-04 | 0.030 | 0.667 | 3 | 2005 | 2014 | |||||
Coronary heart disease
|
1178 | 0.611 | 0.600 | 16 | 50722629 | missense variant | G/C;T | snv | 1.1E-02; 2.2E-04 | 0.010 | 1.000 | 1 | 2007 | 2007 | |||||
Crohn Disease
|
1147 | 0.611 | 0.600 | 16 | 50722629 | missense variant | G/C;T | snv | 1.1E-02; 2.2E-04 | 1.000 | 0.949 | 78 | 2001 | 2019 | |||||
Ulcerative Colitis
|
827 | 0.611 | 0.600 | 16 | 50722629 | missense variant | G/C;T | snv | 1.1E-02; 2.2E-04 | 0.800 | 0.846 | 13 | 2002 | 2018 | |||||
Sarcoidosis
|
787 | 0.611 | 0.600 | 16 | 50722629 | missense variant | G/C;T | snv | 1.1E-02; 2.2E-04 | 0.040 | 0.750 | 4 | 2005 | 2018 | |||||
Cardiovascular Diseases
|
711 | 0.611 | 0.600 | 16 | 50722629 | missense variant | G/C;T | snv | 1.1E-02; 2.2E-04 | 0.010 | 1 | 2010 | 2010 | ||||||
Psoriasis
|
705 | 0.611 | 0.600 | 16 | 50722629 | missense variant | G/C;T | snv | 1.1E-02; 2.2E-04 | 0.710 | 1.000 | 2 | 2006 | 2016 | |||||
Stomach Carcinoma
|
652 | 0.611 | 0.600 | 16 | 50722629 | missense variant | G/C;T | snv | 1.1E-02; 2.2E-04 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Malignant neoplasm of stomach
|
615 | 0.611 | 0.600 | 16 | 50722629 | missense variant | G/C;T | snv | 1.1E-02; 2.2E-04 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Ankylosing spondylitis
|
609 | 0.611 | 0.600 | 16 | 50722629 | missense variant | G/C;T | snv | 1.1E-02; 2.2E-04 | 0.730 | 0.750 | 4 | 2002 | 2016 | |||||
Inflammatory Bowel Diseases
|
605 | 0.611 | 0.600 | 16 | 50722629 | missense variant | G/C;T | snv | 1.1E-02; 2.2E-04 | 0.100 | 1.000 | 11 | 2002 | 2017 | |||||
Hepatitis B
|
519 | 0.611 | 0.600 | 16 | 50722629 | missense variant | G/C;T | snv | 1.1E-02; 2.2E-04 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.611 | 0.600 | 16 | 50722629 | missense variant | G/C;T | snv | 1.1E-02; 2.2E-04 | 0.040 | 0.750 | 4 | 2005 | 2008 | |||||
Autoimmune Diseases
|
428 | 0.611 | 0.600 | 16 | 50722629 | missense variant | G/C;T | snv | 1.1E-02; 2.2E-04 | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||
Tuberculosis
|
328 | 0.611 | 0.600 | 16 | 50722629 | missense variant | G/C;T | snv | 1.1E-02; 2.2E-04 | 0.020 | 1.000 | 2 | 2012 | 2013 | |||||
Familial (FPAH)
|
276 | 0.611 | 0.600 | 16 | 50722629 | missense variant | G/C;T | snv | 1.1E-02; 2.2E-04 | 0.030 | 1.000 | 3 | 2003 | 2018 | |||||
Cholangitis, Sclerosing
|
276 | 0.611 | 0.600 | 16 | 50722629 | missense variant | G/C;T | snv | 1.1E-02; 2.2E-04 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Behcet Syndrome
|
243 | 0.611 | 0.600 | 16 | 50722629 | missense variant | G/C;T | snv | 1.1E-02; 2.2E-04 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Hirschsprung Disease
|
162 | 0.611 | 0.600 | 16 | 50722629 | missense variant | G/C;T | snv | 1.1E-02; 2.2E-04 | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||
Sepsis
|
144 | 0.611 | 0.600 | 16 | 50722629 | missense variant | G/C;T | snv | 1.1E-02; 2.2E-04 | 0.020 | 1.000 | 2 | 2007 | 2012 | |||||
Septicemia
|
141 | 0.611 | 0.600 | 16 | 50722629 | missense variant | G/C;T | snv | 1.1E-02; 2.2E-04 | 0.020 | 1.000 | 2 | 2007 | 2012 | |||||
Hamartoma Syndrome, Multiple
|
139 | 0.611 | 0.600 | 16 | 50722629 | missense variant | G/C;T | snv | 1.1E-02; 2.2E-04 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Rectal Carcinoma
|
112 | 0.611 | 0.600 | 16 | 50722629 | missense variant | G/C;T | snv | 1.1E-02; 2.2E-04 | 0.010 | 1.000 | 1 | 2008 | 2008 |